🧠 TOACS Counseling Station ADHD – Pharmacological & Behavioral Management

A structured approach to counseling parents about ADHD treatment options

πŸ“‹ Scenario Station

Parents of a 7-year-old child recently diagnosed with ADHD (combined presentation) Β· seeking counseling about pharmacological and behavioral treatment options.

Task: Provide comprehensive counseling covering medication options, behavioral interventions, school supports, and monitoring.

🧾 Counseling Framework Step-by-Step

1. Establishing Rapport & Setting the Scene

  • Greet the parents warmly; introduce yourself and your role.
  • Ensure privacy and a calm environment; sit at eye level.
  • Acknowledge the parents' concerns about starting treatment.

2. Explaining ADHD Treatment Principles

  • Explain that ADHD is a neurobiological condition with a multimodal treatment approach.
  • State the goal: β€œWe aim to reduce symptoms, improve function, and help your child succeed at school and home.”
  • Emphasize that treatment is a partnership between family, school, and healthcare team.

3. Behavioral Management – First-Line for Preschoolers

  • For children 4-5 years: Parent training in behavior management is first-line (PCIT, Incredible Years, Triple P).
  • For children β‰₯6 years: Behavioral therapy combined with medication is most effective.
  • Key behavioral strategies:
    • Positive reinforcement for desired behaviors
    • Clear, consistent rules and consequences
    • Daily report cards and reward systems
    • Organizational skills training

4. Pharmacological Management – Stimulant Medications

πŸ’Š Methylphenidate

  • Short-acting (Ritalin) – 3-4 hrs
  • Intermediate (Metadate CD) – 6-8 hrs
  • Long-acting (Concerta) – 10-12 hrs
  • Start low (5 mg), titrate weekly

πŸ’Š Amphetamine

  • Short-acting (Adderall) – 4-6 hrs
  • Long-acting (Adderall XR, Vyvanse) – 10-12 hrs
  • Prodrug (Lisdexamfetamine) – lower abuse potential
  • Start low (2.5-5 mg)
  • Stimulants work by increasing dopamine and norepinephrine in prefrontal cortex.
  • Common side effects: decreased appetite, sleep difficulty, headache, stomachache, mood lability.
  • Monitor height, weight, blood pressure, pulse every 3-6 months.

5. Non-Stimulant Medications

🧠 Atomoxetine (Strattera)

  • Selective norepinephrine reuptake inhibitor (SNRI)
  • Slower onset (weeks), lasts 24 hours
  • No abuse potential
  • Useful for comorbid anxiety or tics

🧠 Alpha-2 Agonists

  • Guanfacine ER (Intuniv)
  • Clonidine ER (Kapvay)
  • Also treat tics, aggression, sleep issues
  • Sedation and hypotension may occur
  • Non-stimulants are useful when stimulants are ineffective or cause side effects.
  • May be used as monotherapy or adjunctive therapy.

6. School Supports and Accommodations

  • 504 Plan or IEP: Legal accommodations for ADHD.
  • Common accommodations:
    • Preferential seating (front of class)
    • Extended time on tests and assignments
    • Daily report card and checklists
    • Movement breaks
    • Organizational coaching
    • Reduced distractions (quiet environment)

7. Monitoring and Follow-up

  • Every 3-6 months:
    • Height, weight (plotted on growth chart)
    • Blood pressure, pulse
    • Side effect assessment (appetite, sleep, mood)
    • Academic and behavioral progress
    • Vanderbilt rating scales (parent and teacher)
  • If growth deceleration occurs: consider drug holidays, optimize nutrition, or switch to nonstimulant.

8. Addressing Common Concerns

  • β€œWill medication cause addiction?” Stimulants are not addictive when taken as prescribed; long-acting formulations have lower abuse potential.
  • β€œWill medication stunt growth?” May cause mild growth delay; regular monitoring and dose adjustments minimize risk.
  • β€œCan we stop medication?” Some children may need medication long-term; others may benefit from drug holidays (weekends/school breaks).
  • β€œWhat about heart risks?” Cardiovascular risk is low in children without underlying heart disease; screen for family history of sudden death.

9. Prognosis and Long-Term Outlook

  • ADHD is a lifelong condition in many (~2/3 continue into adulthood).
  • Hyperactivity often decreases with age; inattention and impulsivity may persist.
  • With treatment, children can have successful academic, social, and occupational outcomes.
  • Untreated ADHD is associated with higher risks: accidents, substance use, underemployment.
  • Early and consistent treatment reduces these risks.

10. Closing the Consultation

  • Summarize key points: multimodal treatment, medication options, side effects, monitoring.
  • Invite questions: β€œWhat concerns do you still have?”
  • Provide written resources and contact details.
  • Schedule follow-up to review progress.

πŸ—£οΈ Sample Counseling Dialogue Role-play

Doctor: β€œGood morning. I'm Dr. Ayesha. I understand your child has been diagnosed with ADHD, and you have questions about treatment options. I'm here to help you understand what we can do.”

Mother: β€œWe're worried about medication. Is there a non-drug option?”

Doctor: β€œAbsolutely. ADHD is best treated with a multimodal approach. For a child of your child's age, we recommend a combination of behavioral therapy and medication if needed. Behavioral therapy includes parent training and school supports.”

Father: β€œWhat medications are available?”

Doctor: β€œFirst-line medications are stimulants like methylphenidate or amphetamines. They are effective in about 70-80% of children. They work by balancing brain chemicals that help with attention and impulse control. We start with a low dose and adjust gradually.”

Mother: β€œWhat about side effects?”

Doctor: β€œCommon side effects include decreased appetite, trouble sleeping, and sometimes headaches. We monitor height, weight, and blood pressure regularly. Many of these side effects are manageable with timing of doses and proper nutrition.”

Doctor: β€œWe'll also work with your child's school to set up accommodations β€” like extra time on tests and preferential seating. With consistent treatment, we can help your child succeed.”

πŸ“Œ Examiner's Checklist Assessment

Essential Components

  • βœ“ Rapport & introduction
  • βœ“ Multimodal treatment (behavioral + pharmacological)
  • βœ“ Behavioral therapy (parent training, school supports)
  • βœ“ Stimulant medications (methylphenidate, amphetamine)
  • βœ“ Non-stimulant options (atomoxetine, guanfacine, clonidine)
  • βœ“ Common side effects (appetite, sleep, growth)
  • βœ“ Monitoring (height, weight, BP, pulse)
  • βœ“ School accommodations (504 Plan, IEP)
  • βœ“ Invites questions & provides contact details

Advanced / Bonus

  • βœ“ Drug holidays and long-term planning
  • βœ“ Addressing addiction concerns
  • βœ“ Cardiovascular risk assessment
  • βœ“ Comorbidities (anxiety, tics, ODD)
  • βœ“ Transition planning to adult care

πŸ“ Quick Reference – Key Messages

← TOACS Library Mock Test β†’